Nivolumab to restore T-cell fitness in CAR-T refractory multiple myeloma

被引：0
|
作者：
Waldschmidt, Johannes M. [1 ,2 ,3 ,4 ]
Sotudeh, Noori [1 ,2 ,3 ]
Arora, Sankalp [5 ,6 ]
Vijaykumar, Tushara [1 ,2 ]
Anand, Praveen [1 ,2 ,3 ]
Stuart, Hannah [1 ,2 ,3 ]
Frede, Julia [1 ,2 ,3 ]
Campbell, Tim [7 ]
Kaiser, Shari M. [7 ]
Zheng, Xirong [7 ]
Munshi, Nikhil C. [1 ,2 ]
Anderson, Kenneth C. [1 ,2 ]
Einsele, Hermann [4 ]
Yee, Andrew J. [5 ]
Knoechel, Birgit [2 ,3 ,8 ]
Lohr, Jens G. [1 ,3 ]
Raje, Noopur S. [2 ,3 ,5 ]
机构：
[1] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA USA
[2] Harvard Med Sch, Boston, MA USA
[3] Broad Inst MIT & Harvard, Cambridge, MA USA
[4] Univ Hosp Wurzburg, Dept Internal Med 2, Wurzburg, Germany
[5] Massachussetts Gen Hosp, Ctr Multiple Myeloma, Dept Hematol Oncol, Boston, MA USA
[6] MD ANDERSON CANC CTR, DEPT HEMATOL, HOUSTON, TX USA
[7] Bristol Myers Squibb, Princeton, NJ USA
[8] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA USA
来源：
BLOOD ADVANCES | 2025年 / 9卷 / 05期
关键词：
THERAPY;
D O I：
10.1182/bloodadvances.2024015285
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1132 / 1136
页数：5
相关论文
共 50 条
  • [11] Teclistamab Success in CAR-T Refractory Multiple Myeloma: A Case Presentation
    Fleischmann, Bastian
    Jain, Sayli
    Bello, Adriana
    Zubair, Rabi
    Hempel, Dirk
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S536 - S536
  • [12] Emerging therapies for relapsed/refractory multiple myeloma: CAR-T and beyond
    Christopher T. Su
    J. Christine Ye
    Journal of Hematology & Oncology, 14
  • [13] Emerging therapies for relapsed/refractory multiple myeloma: CAR-T and beyond
    Su, Christopher T.
    Ye, J. Christine
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2021, 14 (01)
  • [14] Selinexor-Containing Regimens for the Treatment of Patients with Multiple Myeloma Refractory to Chimeric Antigen Receptor T-Cell (CAR-T) Therapy
    Chari, Ajai
    Vogl, Dan T.
    Jagannath, Sundar
    Jasielec, Jagoda K.
    DeCastro, Andrew
    Unger, Tj
    Shah, Jatin
    Jakubowiak, Andrzej
    BLOOD, 2019, 134
  • [15] Current Status of CAR-T Cell Therapy in Multiple Myeloma
    Reguera-Ortega, Juan Luis
    Garcia-Guerrero, Estefania
    Perez-Simon, Jose Antonio
    HEMATO, 2021, 2 (04): : 660 - 671
  • [16] Bispecific Antibodies as Bridging to BCMA CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma
    Fandrei, David
    Seiffert, Sabine
    Rade, Michael
    Rieprecht, Susanne
    Gagelmann, Nico
    Born, Patrick
    Wiemers, Thomas
    Weidner, Heike
    Kreuz, Markus
    Schassberger, Tamara
    Kossmann, Jannik
    Mangold, Marlene
    Fuerst, Daniel
    Fischer, Luise
    Baber, Ronny
    Heyn, Simone
    Wang, Song Yau
    Bach, Enrica
    Hoffmann, Sandra
    Metzeler, Klaus H.
    Herling, Marco
    Jentzsch, Madlen
    Franke, Georg-Nikolaus
    Koehl, Ulrike
    Friedrich, Maik
    Boldt, Andreas
    Reiche, Kristin
    Platzbecker, Uwe
    Vucinic, Vladan
    Merz, Maximilian
    BLOOD CANCER DISCOVERY, 2025, 6 (01): : 38 - 54
  • [17] Enhanced platelet function through CAR-T cell therapy in relapsed/refractory multiple myeloma
    Ma, Ruixue
    Zhang, Qi
    Liu, Yang
    Li, Hujun
    Chen, Huimin
    Zhang, Qianqian
    Qiao, Jianlin
    Qi, Kunming
    Shen, Guifang
    Sun, Cai
    Song, Xuguang
    Cao, Jiang
    Cheng, Hai
    Zhu, Feng
    Yan, Zhiling
    Sang, Wei
    Li, Depeng
    Sun, Haiying
    Zheng, Junnian
    Li, Zhenyu
    Xu, Kailin
    Chen, Wei
    CLINICAL AND EXPERIMENTAL MEDICINE, 2024, 24 (01)
  • [18] Total Car-T Cost of Care Beyond the Price of Car-T Cell Therapy in Patients with Multiple Myeloma
    Jagannath, Sundar
    Joseph, Nedra
    Crivera, Concetta
    Jackson, Carolyn C.
    Valluri, Satish
    Cost, Patricia
    Phelps, Hilary
    Slowik, Rafal
    Klein, Timothy
    Yu, Xueting
    Smolen, Lee
    Cohen, Adam D.
    BLOOD, 2021, 138
  • [19] CAR-T Cell Therapy for T-Cell Malignancies
    Testa, Ugo
    Chiusolo, Patrizia
    Pelosi, Elvira
    Castelli, Germana
    Leone, Giuseppe
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2024, 16 (01)
  • [20] Attrition after Referral for Chimeric Antigen Receptor T-Cell (CAR-T) Products in Multiple Myeloma (MM)
    Subramanian, Naveen
    Gurumurthi, Ashwath
    Pasvolsky, Oren
    Ferreri, Christopher
    Lee, Hans C.
    Manasanch, Elisabet E.
    Thomas, Sheeba K.
    Weber, Donna M.
    Gaballa, Mahmoud
    Dillard, Christen
    Becnel, Melody
    Hosing, Chitra
    Lin, Pei
    Amini, Behrang
    Qazilbash, Muzaffar H.
    Kalariya, Nilesh
    Hawkins, Misha
    Ahmed, Sairah
    Orlowski, Robert Z.
    Patel, Krina K.
    BLOOD, 2023, 142
12345